StockWatch
·
Aerospace & Defense
Regulatory27 May 2026, 06:52 pm

DCX Systems: No Deviation in IPO/QIP Fund Utilization

AI Summary

DCX Systems Ltd confirms no deviation or variation in the utilization of IPO proceeds from the Prospectus dated November 04, 2022, and QIP proceeds from the Placement Document dated January 19, 2024, as of March 31, 2026. The Audit Committee reviewed the statement of deviation or variation on May 27, 2026. The IPO raised ₹400.00 Crs, with ₹26.97 Crs spent on issue expenses, leaving ₹373.03 Crs for utilization. The QIP raised ₹500.00 Crs, with ₹13.35 Crs spent on issue expenses, leaving ₹486.65 Crs for utilization. CARE Ratings Limited was the monitoring agency.

Key Highlights

  • DCX Systems reports no deviation in IPO/QIP fund utilization as of March 31, 2026.
  • IPO proceeds were ₹400.00 Crs with ₹373.03 Crs available after expenses.
  • QIP proceeds were ₹500.00 Crs with ₹486.65 Crs available after expenses.
  • Audit Committee reviewed the statement on May 27, 2026.
  • CARE Ratings Limited served as the monitoring agency.